Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.
The Biden administration has—for the second time—delayed the decision on a proposed FDA rule that would ban menthol cigarettes and all flavors in cigars.
A coalition of health and physician groups earlier this week filed a lawsuit seeking to force FDA to finalize a long-delayed final rule banning menthol cigarettes.
President Joe Biden has requested an increase of $871.5 million to the overall NIH budget in FY25. Of that amount, $522 million, or nearly 60%, is slated for NCI.
Source: White HouseIn a fiery State of the Union speech designed to showcase his performance as a veteran politician, President Joe Biden leaned into his accomplishments in health care.
Invoking the Defense Production Act, President Joe Biden has ordered federal agencies and artificial intelligence companies to create safeguards and standards for the technology that has the capacity to uplift humankind as much as it can wreak unimaginable harm.
President Joe Biden on Nov. 17 announced his intent to appoint W. Kimryn Rathmell as NCI director.
The Advanced Research Projects Agency for Health will issue $240 million in cancer-related awards over the next few weeks, the White House announced at a Cancer Cabinet meeting Sept. 13.
The first 10 drugs selected for price negotiations under Medicare Part D program includes only one oncology drug: ibrutinib (Imbruvica), a tyrosine kinase inhibitor indicated for the treatment of blood cancers, including chronic lymphocytic leukemia and small lymphocytic lymphoma.
The White House has awarded NCI $50 million to establish five centers for cancer control research in persistent poverty areas.